Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADOAIR plus Tiotropium vs Individual Components in Japanese COPD
NCT01751113Phase 4Completed
- Sponsor
- GSK
- Start
- Feb 2013
- Primary completion
- Nov 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of fluticasone propionate, salmeterol, tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Feb 2013; status: completed.
02
Drugs
fluticasone propionatesalmeteroltiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01751113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01751113.